Advances in Targeted Therapies for Triple-Negative Breast Cancer

被引：72

作者：

McCann, Kelly E. ^{[1
]}

Hurvitz, Sara A. ^{[1
]}

McAndrew, Nicholas ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, 2336 Santa Monica,Suite 304, Los Angeles, CA 90404 USA

来源：

DRUGS | 2019年 / 79卷 / 11期

关键词：

SACITUZUMAB GOVITECAN; 1ST-LINE THERAPY; DOUBLE-BLIND; PARP; INHIBITOR; PALBOCICLIB; FULVESTRANT; SUBTYPES; AKT; IMMUNOTHERAPY;

D O I：

10.1007/s40265-019-01155-4

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

While the outcomes for patients diagnosed with hormone receptor positive (HR+) and/or human epidermal growth factor receptor 2-positive (HER2+) breast cancers have continued to improve with the development of targeted therapies, the same cannot be said yet for those affected with triple-negative breast cancer (TNBC). Currently, the mainstay of treatment for the 10- 15% of patients diagnosed with TNBC remains cytotoxic chemotherapy, but it is hoped that through an enhanced characterization of TNBC biology, this disease will be molecularly delineated into subgroups with targetable oncogenic drivers. This review will focus on recent therapeutic innovations for TNBC, including poly-ADP-ribosyl polymerase (PARP) inhibitors, phosphoinositide 3-kinase (PI3K) pathway inhibitors, immune checkpoint inhibitors, and cyclin-dependent kinase (CDK) inhibitors.

引用

页码：1217 / 1230

页数：14

共 67 条

[61] Poly(ADP-ribose):: novel functions for an old molecule [J].

Schreiber, Valerie ;

Dantzer, Francoise ;

Ame, Jean-Christophe ;

de Murcia, Gilbert .

NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (07) :517-528

[62] Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3 [J].

Slamon, Dennis J. ;

Neven, Patrick ;

Chia, Stephen ;

Fasching, Peter A. ;

De Laurentiis, Michelino ;

Im, Seock-Ah ;

Petrakova, Katarina ;

Bianchi, Giulia Val ;

Esteva, Francisco J. ;

Martin, Miguel ;

Nusch, Arnd ;

Sonke, Gabe S. ;

De la Cruz-Merino, Luis ;

Beck, J. Thaddeus ;

Pivot, Xavier ;

Vidam, Gena ;

Wang, Yingbo ;

Lorenc, Karen Rodriguez ;

Miller, Michelle ;

Taran, Tetiana ;

Jerusalem, Guy .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (24) :2465-+

[63] MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy [J].

Sledge, George W., Jr. ;

Toi, Masakazu ;

Neven, Patrick ;

Sohn, Joohyuk ;

Inoue, Kenichi ;

Pivot, Xavier ;

Burdaeva, Olga ;

Okera, Meena ;

Masuda, Norikazu ;

Kaufman, Peter A. ;

Koh, Han ;

Grischke, Eva-Maria ;

Frenzel, Martin ;

Lin, Yong ;

Barriga, Susana ;

Smith, Ian C. ;

Bourayou, Nawel ;

Llombart-Cussac, Antonio .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (25) :2875-+

[64] First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors [J].

Starodub, Alexander N. ;

Ocean, Allyson J. ;

Shah, Manish A. ;

Guarino, Michael J. ;

Picozzi, Vincent J., Jr. ;

Vahdat, Linda T. ;

Thomas, Sajeve S. ;

Govindan, Serengulam V. ;

Maliakal, Pius P. ;

Wegener, William A. ;

Hamburger, Steven A. ;

Sharkey, Robert M. ;

Goldenberg, David M. .

CLINICAL CANCER RESEARCH, 2015, 21 (17) :3870-3878

[65] Integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer [J].

Stemke-Hale, Katherine ;

Gonzalez-Angulo, Ana Maria ;

Lluch, Ana ;

Neve, Richard M. ;

Kuo, Wen-Lin ;

Davies, Michael ;

Carey, Mark ;

Hu, Zhi ;

Guan, Yinghui ;

Sahin, Aysegul ;

Symmans, W. Fraser ;

Pusztai, Lajos ;

Nolden, Laura K. ;

Horlings, Hugo ;

Berns, Katrien ;

Hung, Mien-Chie ;

van de Vijver, Marc J. ;

Valero, Vicente ;

Gray, Joe W. ;

Bernards, Rene ;

Mills, Gordon B. ;

Hennessy, Bryan T. .

CANCER RESEARCH, 2008, 68 (15) :6084-6091

[66] Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors [J].

Wahlberg, Elisabet ;

Karlberg, Tobias ;

Kouznetsova, Ekaterina ;

Markova, Natalia ;

Macchiarulo, Antonio ;

Thorsell, Ann-Gerd ;

Pol, Ewa ;

Frostell, Asa ;

Ekblad, Torun ;

Oncu, Delal ;

Kull, Bjorn ;

Robertson, Graeme Michael ;

Pellicciari, Roberto ;

Schuler, Herwig ;

Weigelt, Johan .

NATURE BIOTECHNOLOGY, 2012, 30 (03) :283-+

[67] Causes and consequences of replication stress [J].

Zeman, Michelle K. ;

Cimprich, Karlene A. .

NATURE CELL BIOLOGY, 2014, 16 (01) :2-9

← 1 2 3 4 5 6 7 →